Skip to content

KPCB XV Associates, LLC 13F Holdings · last filed Q3 2022

KPCB XV Associates, LLC reported 3 securities worth $35.84M in its SEC 13F filing for Q3 2022 (period ended 2022-09-30). Top holdings: RAPT (43.54%), TWLO (36.66%), ATRA (19.79%). Among its top 25 positions this quarter: 1 trimmed, 1 exited.

RankTickerCompanyValue% PortfolioSharesAction
1RAPTRapt Therapeutics, Inc.$15.6M43.54%648,531Trimmed
2TWLOTwilio Inc.$13.1M36.66%190,047Hold
3ATRAAtara Biotherapeutics, Inc.$7.1M19.79%1.9MHold
4AUGXAugmedix, Inc.$00.00%0Exited

Source: SEC Form 13F filings · as of 2022-09-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR